Welcome to our dedicated page for Axt news (Ticker: AXTI), a resource for investors and traders seeking the latest updates and insights on Axt stock.
AXT, Inc. reports developments around its business as a manufacturer of compound and single-element semiconductor substrate wafers. The company develops and manufactures indium phosphide, gallium arsenide and germanium wafers used where silicon substrates do not meet performance requirements for semiconductor or optoelectronic devices, including fiber optic and 5G communications, data center connectivity, LEDs, lasers, photonic integrated circuits, lidar and advanced sensing.
Recurring AXTI news includes financial results, earnings-release scheduling, common stock financing, and capacity or research spending tied to indium phosphide substrates through Beijing Tongmei Xtal Technology Co., Ltd. Coverage also includes market products linked to AXTI shares, such as single-stock leveraged ETFs that reference the company’s daily stock performance.
REX Shares (Cboe: AXTU) launched the T-REX 2X Long AXTI Daily Target ETF on May 5, 2026, providing 2x daily long exposure to AXT, Inc. (Nasdaq: AXTI).
AXTU targets 200% of AXTI's daily performance and expands the T-REX suite to over 40 leveraged and inverse single-stock ETFs. The fund is aimed at traders and carries significant leverage, compounding, and daily-monitoring risks.
AXT (NasdaqGS: AXTI) reported Q1 2026 results: revenue $26.9M, GAAP gross margin 29.6%, and GAAP net loss after minority interests of $1.6M ($0.03/share). The company completed a $632.5M capital raise to support Tongmei's indium phosphide capacity expansion and R&D. Tongmei's STAR Market IPO remains subject to CSRC review.
AXT (NasdaqGS: AXTI) announced that underwriters exercised the full over-allotment option in its recent public offering, purchasing an additional 1,284,046 shares at $64.25 per share for approximately $82.5 million in additional gross proceeds. The original offering comprised 8,560,311 shares, bringing total shares sold to 9,844,357.
According to the company, net proceeds will primarily support its Beijing subsidiary's capacity expansion for indium phosphide substrate production for export, fund research and development, and provide working capital and general corporate purposes. The shelf registration was filed April 20, 2026.
Tradr ETFs will launch four single-stock 2X leveraged ETFs on Cboe on April 24, 2026, each seeking 200% of the daily performance of its underlying stock.
Expected launches include AXTX (AXTI), CPNX (CPNG), MPWX (MPWR) and STXX (STX). The issuer highlighted significant risks of leveraged ETFs and directs investors to its website for full disclosures.
AXT (NasdaqGS: AXTI) closed an underwritten public offering of 8,560,311 common shares at $64.25 per share, generating approximately $550 million in gross proceeds.
The underwriter has a 30-day Overallotment Option for an additional 1,284,046 shares, which if exercised would raise aggregate gross proceeds to about $632.5 million. The company intends to use net proceeds to support its Beijing subsidiary’s indium phosphide capacity expansion, fund R&D, and for working capital and general corporate purposes.
AXT (NasdaqGS: AXTI) priced an underwritten public offering of 8,560,311 shares at $64.25 per share, expected to raise approximately $550 million in gross proceeds before fees. The underwriter has a 30-day Overallotment Option for 1,284,046 additional shares, potentially increasing gross proceeds to $632.5 million.
Closing is expected on or about April 22, 2026, subject to customary conditions. Net proceeds are intended to support subsidiary Beijing Tongmei Xtal Technology's capacity expansion for indium phosphide substrate exports, R&D, working capital, and general corporate purposes.
AXT (NasdaqGS: AXTI) announced an intended public offering of common stock on April 20, 2026, with an underwriter Overallotment Option of up to 15% of the shares. Net proceeds are planned to support subsidiary Beijing Tongmei Xtal Technology’s capacity expansion, R&D, working capital and general corporate purposes.
The offering is subject to market conditions; final terms will be disclosed in a prospectus supplement filed with the SEC.
AXT (NasdaqGS: AXTI) will release first quarter 2026 financial results after market close on April 30, 2026 and hold a conference call the same day at 1:30 p.m. PT.
Investors can join by phone (833-461-5787, passcode 619252830) or via live webcast at www.axt.com. The webcast will remain available through April 30, 2027.
AXT (NasdaqGS: AXTI) reported fourth quarter and fiscal year 2025 results, with Q4 revenue $23.0M and fiscal 2025 revenue $88.3M. GAAP gross margin fell to 12.7% for fiscal 2025 and GAAP net loss widened to $21.3M ($0.49/share). Management said permit receipts improved in early 2026 and the company expects sequential revenue growth in Q1 as it doubles indium phosphide capacity.
The company will host a conference call today at 1:30 p.m. PT and noted the STAR Market IPO process for its Tongmei subsidiary remains under regulatory review.
AXT (Nasdaq: AXTI) updated its Q4 2025 revenue outlook to $22.5–$23.5 million, citing fewer export permits for indium phosphide issued by China’s Ministry of Commerce that limited December shipments. The company said customer demand remains strong and expects additional permits in Q1 2026. AXT completed a capital raise in December and plans to use proceeds to expand manufacturing capacity, targeting more than double indium phosphide capacity in the second half of 2026 to support AI and optical connectivity demand.
AXT will release Q4 2025 results and host an earnings call on Feb 19, 2026 at 1:30 p.m. PT; replay available through Feb 26, 2026.